Haemonetics Corp. (HAE)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity | Share change | % change to portfolio ▲ | |
| Q1 2024 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 6,074 | 0.01 | |
| Q4 2019 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 9,207 | 0.02 | |
| Q2 2019 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 89,560 | 0.16 | |
| Q3 2018 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 20,830 | 0.03 | |
| Q1 2014 | |||||
| ≡ | Robert Olstein - Olstein Capital Management | Buy | 11,000 | 0.06 | |
| Q2 2013 | |||||
| ≡ | Meridian Contrarian Fund | Add 12.55% | 49,000 | 0.30 | |
| Q1 2013 | |||||
| ≡ | Meridian Contrarian Fund | Add 10.12% | 35,900 | 0.22 | |
| Q3 2012 | |||||
| ≡ | Meridian Contrarian Fund | Add 21.86% | 63,600 | 0.40 | |
| Q2 2012 | |||||
| ≡ | Meridian Contrarian Fund | Buy | 291,000 | 1.70 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.